SCHEMBL2597221

SCHEMBL2597221

COC(=O)c1ccc(OC2CCN(C3CCN(C(=O)OC(C)(C)C)CC3)C2=O)c(F)c1

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 6/20 0.47
FPR2 P25090 1/20 0.46
TP53 P04637 2/20 0.44
PDE4D Q08499 3/20 0.43
PDE4A P27815 2/20 0.43
PDE4B Q07343 2/20 0.43
PDE4C Q08493 2/20 0.43
KMT2A Q03164 2/20 0.42
ALDH1A1 P00352 1/20 0.41
STS P08842 1/20 0.40
CTSD P07339 1/20 0.39
CTSE P14091 1/20 0.39
BACE1 P56817 1/20 0.39
MAPT P10636 1/20 0.39
THRB P10828 1/20 0.39
SCN9A Q15858 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14918071 1.00 GPR119 (0.47) GPR119FPR2TP53PDE4DPDE4A
SCHEMBL2596997 0.91 GPR119 (0.48) GPR119FPR2TP53PDE4DPDE4A
SCHEMBL2596996 0.91 GPR119 (0.48) GPR119FPR2TP53PDE4DPDE4A
SCHEMBL15022866 0.88 KMT2A (0.48) GPR119FPR2TP53PDE4DPDE4A
SCHEMBL2597085 0.88 KMT2A (0.48) GPR119FPR2TP53PDE4DPDE4A
SCHEMBL790187 0.86 FPR2 (0.55) GPR119FPR2TP53PDE4DPDE4A
SCHEMBL14917753 0.86 FPR2 (0.55) GPR119FPR2TP53PDE4DPDE4A
Hydrochloric Acid SCHEMBL14918155 0.84 ALOX15 (0.40) FPR2TP53KMT2AALDH1A1MAPT
Hydrochloric Acid SCHEMBL2597136 0.84 ALOX15 (0.40) FPR2TP53KMT2AALDH1A1MAPT
SCHEMBL789139 0.83 GPR119 (0.68) GPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140256756-A1 PIPERIDINYL-SUBSTITUTED LACTAMS AS GPR119 MODULATORS ARRAY BIOPHARMA, INC. 2014-09-11 US disclosed
US-8754226-B2 Piperidinyl-substituted lactams as GPR119 modulators ARRAY BIOPHARMA INC. (US) 2014-06-17 US disclosed
US-20130158009-A1 PIPERIDINYL-SUBSTITUTED LACTAMS AS GPR119 MODULATORS ARRAY BIOPHARMA, INC. 2013-06-20 US disclosed
WO-2013066869-A1 PIPERIDINYL-SUBSTITUTED LACTAMS AS GPR119 MODULATORS ARRAY BIOPHARMA INC. (US) 2013-05-10 WO disclosed
EP-2571864-A1 PIPERIDINYL-SUBSTITUTED LACTAMS AS GPR119 MODULATORS Array Biopharma, Inc. (US) 2013-03-27 EP disclosed
WO-2011146335-A1 PIPERIDINYL-SUBSTITUTED LACTAMS AS GPR119 MODULATORS ARRAY BIOPHARMA INC. (US) 2011-11-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140256756-A1 PIPERIDINYL-SUBSTITUTED LACTAMS AS GPR119 MODULATORS GPR119, GPR139, GLP1R GPR119 1/4885FPR2 142/4885TP53 4810/4885
US-20130158009-A1 PIPERIDINYL-SUBSTITUTED LACTAMS AS GPR119 MODULATORS GPR119, GPR139, GPR39 GPR119 1/4885FPR2 328/4885TP53 4790/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.